Development of radiolabeling methods for the in vivo tracking of immune cells during adoptive cell therapy

Bidragets beskrivning

Adoptive cell therapy using cytotoxic, tumor-targeting immune cells has emerged as a promising treatment modality in select cancers. The aim of the project is to develop sensitive and quantitative nuclear molecular imaging tools for the tracking on transplanted immune cells and their progeny in a mouse model of metastatic melanoma. We propose to employ selective and fast bioorthogonal reactions to generate radiolabeled tracers based on direct labeling of transplanted cells, growth factors, and antibodies. The research will provide important tools for the monitoring of the success of ACT in living systems, and for the development of safer and more effective ACT therapies.
Visa mer

Startår

2018

Slutår

2023

Beviljade finansiering

Mirkka Sarparanta Orcid -palvelun logo
438 874 €

Andra beslut

346122
Akademiforskarens forskningskostnader(2021)
159 997 €
320102
Akademiforskarens forskningskostnader(2018)
209 980 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiforskare

Övriga uppgifter

Finansieringsbeslutets nummer

318422

Vetenskapsområden

Kemi

Forskningsområden

Kemia

Identifierade teman

cancer